Abu Dhabi, United Arab Emirates:
UAE headquartered investment group Yas Holding LLC has completed the acquisition of a significant majority shareholding in Geltec Healthcare FZE. Located in Dubai’s Jebel Ali area, Geltec Healthcare FZE is part of a renowned pharma and nutraceutical group with a global presence. The acquisition was completed through Yas Holding’s dedicated healthcare investment group, Global One Healthcare Holding LLC.
The facility is geared to produce dietary supplements and pharmaceutical products in soft gelatine capsules and gelatine enrobed tablets, with a rated manufacturing capacity of 1.5 billion units per annum.
The company has a state-of-the-art manufacturing facility, which is the largest soft gelatine capsule manufacturing and packaging facility in the region, with the scope to expand into various other dosage forms.
Yas Holding plans to invest in further plant expansion to include oral solid tablets, and potentially inhalers and/or injectable lines. The facility is approved by the UAE Ministry of Health and has also received GCC and EU GMP certifications, amongst other approvals.
Commenting on the latest acquisition, Mr. Murshed Al Redaini, Group Chief Executive Officer of Yas Holding said ‘Yas Holding is pleased to announce our acquisition of Geltec Healthcare FZE. The addition of their production facilities in the UAE will bring further strength to our pharmaceutical manufacturing and distribution value chain, whilst also complementing our existing healthcare portfolio.”
He further added “Our Healthcare Division continues to expand as we aim to realise our strategy of becoming a significant player in the region's healthcare industry. With recent investments in leading bio-pharmaceuticals and innovative manufacturing solutions, Yas Holding is delivering on its commitment to healthcare outcomes and patient quality of life. Our
healthcare portfolio includes biopharma, medical supply chain provision, hospital and clinic management, manufacturing, healthcare technology, and occupational health and wellness.”
Notably, Yas Holding had earlier acquired WellPharma Medical Solutions which is the UAE’s first and only IV solutions manufacturing plant to cater to the ever-growing demand for life- saving IV solutions in DEHP-free containers and bags.
-Ends-
About Yas Holding LLC
Yas Holding is a UAE headquartered investment company with a multi-business portfolio spanning 9 sectors, 7500 employees, and 60 operating subsidiaries. The group is in growth mode, with expanding business interests in agriculture, food, healthcare, education, aviation, real estate, FMCG, technology & services. Yas Holding’s diverse companies operate across the Middle East, Africa, Europe, and Asia.
Yas Holding Contact:
Kerry Reid
Group Head of Marketing
Email: Kerry.reid@yasholding.ae
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
